170 related articles for article (PubMed ID: 24236648)
21. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
Cantarovich D
J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
[TBL] [Abstract][Full Text] [Related]
22. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
23. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
24. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
[TBL] [Abstract][Full Text] [Related]
25. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653
[TBL] [Abstract][Full Text] [Related]
26. Minimization and withdrawal of steroids in pancreas and islet transplantation.
Mineo D; Sageshima J; Burke GW; Ricordi C
Transpl Int; 2009 Jan; 22(1):20-37. PubMed ID: 18855850
[TBL] [Abstract][Full Text] [Related]
27. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
28. Single-agent immunosuppression after liver transplantation: what is possible?
Raimondo ML; Burroughs AK
Drugs; 2002; 62(11):1587-97. PubMed ID: 12109922
[TBL] [Abstract][Full Text] [Related]
29. Withdrawal of immunosuppression: implications for composite tissue allograft transplantation.
Hricik DE
Transplant Proc; 1998 Sep; 30(6):2721-3. PubMed ID: 9745554
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppression: practice and trends.
Kaufman DB; Shapiro R; Lucey MR; Cherikh WS; T Bustami R; Dyke DB
Am J Transplant; 2004; 4 Suppl 9():38-53. PubMed ID: 15113354
[TBL] [Abstract][Full Text] [Related]
31. Immune minimization strategies in renal transplantation.
Brar JE; Nader ND
Immunol Invest; 2014; 43(8):807-18. PubMed ID: 25296235
[TBL] [Abstract][Full Text] [Related]
32. Optimal immunosuppression in pancreas transplantation.
Stratta RJ
Transplant Proc; 1999; 31(1-2):619-21. PubMed ID: 10083263
[No Abstract] [Full Text] [Related]
33. Induction therapy in renal transplant recipients: a review.
Laftavi MR; Sharma R; Feng L; Said M; Pankewycz O
Immunol Invest; 2014; 43(8):790-806. PubMed ID: 25296234
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppression in the pediatric transplant recipient.
Blondet NM; Healey PJ; Hsu E
Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
[TBL] [Abstract][Full Text] [Related]
35. An overview of immunosuppression in solid organ transplantation.
Enderby C; Keller CA
Am J Manag Care; 2015 Jan; 21(1 Suppl):s12-23. PubMed ID: 25734416
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppression in the era of biological agents.
Grinyó JM; Cruzado JM; Bestard O; Vidal Castiñeira JR; Torras J
Adv Exp Med Biol; 2012; 741():60-72. PubMed ID: 22457103
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppression: evolution in practice and trends, 1994-2004.
Meier-Kriesche HU; Li S; Gruessner RW; Fung JJ; Bustami RT; Barr ML; Leichtman AB
Am J Transplant; 2006; 6(5 Pt 2):1111-31. PubMed ID: 16613591
[TBL] [Abstract][Full Text] [Related]
38. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.
Krenzien F; ElKhal A; Quante M; Rodriguez Cetina Biefer H; Hirofumi U; Gabardi S; Tullius SG
Transplantation; 2015 Nov; 99(11):2258-68. PubMed ID: 26244716
[TBL] [Abstract][Full Text] [Related]
39. [Modern immunosuppression after solid organ transplantation].
Beimler J; Morath C; Zeier M
Internist (Berl); 2014 Feb; 55(2):212-22. PubMed ID: 24518922
[TBL] [Abstract][Full Text] [Related]
40. Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients.
Smedman TM; Line PD; Guren TK; Dueland S
Acta Oncol; 2018 Oct; 57(10):1414-1418. PubMed ID: 29912605
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
